Share on LinkedInShare on LinkedIn

ARTICLE · 09 MARCH 2013

Appeal lodged in gene patents decision

An appeal from Justice Nichols' decision about the patentability of isolated DNA may be heard after a similar US ruling.

AustraliaIntellectual Property
Marie Mittiga
Marie Mittiga
Megan Fraser
Megan Fraser
Author LinkedIn connections
Focus: Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65
Services: Intellectual Property & Technology, Commercial
Industry Focus: Medical & Pharmaceutical

Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65

On 15 February 2013, Justice Nicholas of the Federal Court of Australia delivered the first Australian decision regarding the validity of gene patents.

At issue was whether a valid patent may be granted for a claim that covers the composition of isolated nucleic acid, being DNA or RNA, from a naturally occurring sequence.1 Significantly, Justice Nicholas determined that a valid patent can be granted for such a claim.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from